An unusual pseudolymphoma in the context of necrotizing fasciitis: A case report.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
23 Dec 2022
Historique:
entrez: 3 1 2023
pubmed: 4 1 2023
medline: 6 1 2023
Statut: ppublish

Résumé

The diagnosis of lymphoma in routine diagnostics can be challenging due to clinical, morphological and immunphenotypical overlap with unusual reactive processes termed "pseudolymphomas." 45-year-old male that underwent surgical debridement for a necrotizing fasciitis of the thigh with concomitant excision of a regional lymph node. The lymph node demonstrated an architecture-effacing activation and proliferation of lymphoblasts and was initially misdiagnosed as an aggressive lymphoma. Only in consideration of the clinical context and with the help of additional immunohistochemical and molecular analyses the final diagnosis of a reactive lymphadenopathy could be made. No further therapy was required after the final diagnosis of a reactive lymphadenopathy was made. The clinical follow-up was unremarkable, with no evidence of residual disease after 6 months. This case report adds the parafollicular activation and proliferation of blasts and plasmablasts in the drainage area of an active infection to the spectrum of "pseudolymphomas" and reiterizes the importance of placing histopathological findings in the proper context.

Identifiants

pubmed: 36595811
doi: 10.1097/MD.0000000000032457
pii: 00005792-202212230-00072
pmc: PMC9794286
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e32457

Informations de copyright

Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

The authors have no funding and conflicts of interest to disclose.

Références

Laurent C, Baron M, Amara N, et al. Impact of expert pathologic review of lymphoma diagnosis: study of patients from the French Lymphopath Network. J Clin Oncol. 2017;35:2008–17.
Lester JF, Dojcinov SD, Attanoos RL, et al. The clinical impact of expert pathological review on lymphoma management: a regional experience. Br J Haematol. 2003;123:463–8.
Brown JR, Skarin AT. Clinical mimics of lymphoma. Oncologist. 2004;9:406–16.
Chan JK, Kwong YL. Common misdiagnoses in lymphomas and avoidance strategies. Lancet Oncol. 2010;11:579–88.
Attygalle AD, Cabeçadas J, Gaulard P, et al. Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward—report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology. Histopathology. 2014;64:171–99.
Wilkins BS. Pitfalls in lymphoma pathology: avoiding errors in diagnosis of lymphoid tissues. J Clin Pathol. 2011;64:466–76.
Weiss LM, O'Malley D. Benign lymphadenopathies. Mod Pathol. 2013;26:S88–96.
O’Malley DP, Grimm KE. Reactive lymphadenopathies that mimic lymphoma: entities of unknown etiology. Semin Diagn Pathol. 2013;30:137–45.
Li J, Zhao S, Wang J, et al. CD20-negative diffuse large B cell lymphoma: a comprehensive analysis of 695 cases. Tumor Biol. 2016;37:3619–37.
Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Lyon: IARC, 2017. 5th edition.

Auteurs

Bastian Dislich (B)

Institute of Pathology, University of Bern, Bern, Switzerland.

Dennis Hoch (D)

Department of Medical Oncology, Inselspital, Bern University Hospital, Bern, Switzerland.

Stefan Dirnhofer (S)

Institute of Pathology, University Hospital Basel, Basel, Switzerland.

Urban Novak (U)

Department of Medical Oncology, Inselspital, Bern University Hospital, Bern, Switzerland.

Yara Banz (Y)

Institute of Pathology, University of Bern, Bern, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH